Paclitaxel

Drug ingredient

CAS 33069-62-4

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

US productionNot reported

Import value, 2024$3.5B

Top sourceIreland 57%

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Production is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.

Where It Comes From

Customs basis: HS 293299 · basket

These shares come from HS customs code 293299, which covers 229 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.

Source Countries

Country of origin for US imports, from Census customs data (2024).

IE 57%IrelandNL 24%NetherlandsCH 8%SwitzerlandCN 5%ChinaIT 2%Italy

United Kingdom
Japan
Germany
Spain
Israel
Canada
Brazil
Vietnam
Ukraine
New Zealand
Belgium
Mexico
Singapore
Taiwan
South Korea
Sweden
South Africa
Egypt
Indonesia
Lithuania
Finland
Hungary
Czech Republic
Hong Kong
Malaysia
Slovakia
Australia
Russia
Jordan
Latvia
Argentina
Slovenia
Malta
Poland
Denmark
Austria

38 FDA-registered drug labelers

Abraxis BioScience, LLC

Alembic Pharmaceuticals Inc.

Alembic Pharmaceuticals Limited

American Regent, Inc.

Aurobindo Pharma Limited

Bamboo US Bidco LCC

BluePoint Laboratories

Chongqing Sintaho Pharmaceutical Co., Ltd.

Cipla USA Inc.

Corden Pharma Boulder, Inc.

Corden Pharma Colorado, Inc.

Fresenius Kabi USA, LLC

Fujian South Pharmaceutical Co. Ltd.

Gland Pharma Limited

Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

Hetero Labs Limited

Hospira, Inc.

Indena SpA

Meitheal Pharmaceuticals Inc.

MSN Laboratories Private Limited

Mylan Institutional LLC

Natco Pharma USA LLC

Ningbo Shuangcheng Pharmaceutical Co., Ltd

NorthStar Rx LLC

Novadoz Pharmaceuticals LLC

Phyton Biotech LLC

Sagent Pharmaceuticals

Sandoz Inc

ScinoPharm Taiwan Ltd.

SERIPHARM

Seripharm S.A.S.

TAPI Czech Industries s.r.o.

Teva Czech Industries s.r.o

Teva Parenteral Medicines, Inc.

Teva Pharmaceuticals, Inc.

Upsher-Smith Laboratories, LLC

Wuhan Calmland Pharmaceuticals Co., Ltd.

Yung Shin Pharmaceutical Ind. Co., Ltd.

Why It Matters

Sectors

Health

Downstream Uses

Appears in 6 drug and cosmetic product listings (FDA).

•Paclitaxel protein-bound particles for injectable suspension (albumin-bound)
•Paclitaxel
•Paclitaxel Paclitaxel
•Paclitaxel protein-bound particles
•Abraxane
•Paclitaxel Protein Bound Particles Albumin Bound

FDA Shortage Status

Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."

No FDA shortage records

Chemical Identity

CAS33069-62-4

PubChem CID36314

DTXSIDDTXSID9023413

FormulaC47H51NO14

Mol. Weight853.9 g/mol

SMILESCC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C

Data Sources

PubChem · compound 36314Retrieved 2026-04-07
FDA National Drug Code directoryRetrieved 2026-04-25
FDA National Drug Code directoryRetrieved 2026-04-07
US Census international tradeReporting year: 2024 · Retrieved 2026-10-04

← Back to Dashboard ← Back to Health

Brief citations

Paclitaxel (CAS 33069-62-4) https://chemicalindependence.com/chemical/33069-62-4/ PubChem: 36314. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/36314 FDA National Drug Code directory: CAS 33069-62-4. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/ US Census international trade: HS 293299 for CAS 33069-62-4. Reporting year: 2024. https://usatrade.census.gov/